GWP
GILD icon

Gen-Wealth Partners’s Gilead Sciences GILD Stock Holding History

Gen-Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.4K Buy
169
+10
+6% +$1.32K 0.01% 489
2026
Q1 		$22.2K Sell
159
-18
-10% -$2.52K 0.01% 471
2025
Q4 		$21.7K Sell
177
-15
-8% -$1.82K 0.01% 467
2025
Q3 		$21.3K Sell
192
-37
-16% -$4.21K 0.01% 462
2025
Q2 		$25.4K Sell
229
-20
-8% -$2.13K 0.01% 394
2025
Q1 		$27.9K Sell
249
-101
-29% -$10.4K 0.01% 386
2024
Q4 		$32.3K Sell
350
-88
-20% -$7.92K 0.01% 396
2024
Q3 		$38.7K Sell
438
-47
-10% -$3.59K 0.02% 396
2024
Q2 		$33.3K Sell
485
-62
-11% -$4.14K 0.02% 406
2024
Q1 		$40.1K Buy
+547
New +$42.1K 0.02% 388

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Gen-Wealth Partners's GILD Position: Q2 2026 in Review

Gen-Wealth Partners increased its Gilead Sciences (GILD) stake by 6.3% in Q2 2026, buying an estimated $1.32K and bringing the position to 169 shares worth $21.4K. The position accounts for 0.01% of the portfolio, ranked #489.

Gen-Wealth Partners first reported a position in GILD in Q1 2024 and has held it in 10 quarters since. The position peaked at $40.1K in Q1 2024. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Gen-Wealth Partners held 169 shares of Gilead Sciences worth $21.4K as of Q2 2026.
  • Gen-Wealth Partners bought 10 Gilead Sciences shares in Q2 2026, an estimated $1.32K.
  • Gilead Sciences made up 0.01% of Gen-Wealth Partners's portfolio in Q2 2026, its #489 holding.
  • Gen-Wealth Partners first reported a position in Gilead Sciences in Q1 2024 and has held it in 10 quarters since.
  • Gen-Wealth Partners's Gilead Sciences position peaked at $40.1K in Q1 2024.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Gen-Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.